EXEL Industries Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

EXEL Industries wird ein jährliches Gewinn- und Umsatzwachstum von 5.7% bzw. 2.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 4.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9.2% betragen.

Wichtige Informationen

5.7%

Wachstumsrate der Gewinne

4.9%

EPS-Wachstumsrate

Machinery Gewinnwachstum43.4%
Wachstumsrate der Einnahmen2.2%
Zukünftige Eigenkapitalrendite9.2%
Analystenabdeckung

Low

Zuletzt aktualisiert05 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

EXEL Industries (EPA:EXE) Has More To Do To Multiply In Value Going Forward

Jun 15
EXEL Industries (EPA:EXE) Has More To Do To Multiply In Value Going Forward

EXEL Industries (EPA:EXE) Will Pay A Larger Dividend Than Last Year At €1.57

Jan 30
EXEL Industries (EPA:EXE) Will Pay A Larger Dividend Than Last Year At €1.57

Is EXEL Industries (EPA:EXE) A Risky Investment?

Jan 28
Is EXEL Industries (EPA:EXE) A Risky Investment?

Be Wary Of EXEL Industries (EPA:EXE) And Its Returns On Capital

Dec 22
Be Wary Of EXEL Industries (EPA:EXE) And Its Returns On Capital

An Intrinsic Calculation For EXEL Industries SA (EPA:EXE) Suggests It's 37% Undervalued

Nov 22
An Intrinsic Calculation For EXEL Industries SA (EPA:EXE) Suggests It's 37% Undervalued

EXEL Industries (EPA:EXE) Is Reducing Its Dividend To €1.05

Jan 05
EXEL Industries (EPA:EXE) Is Reducing Its Dividend To €1.05

EXEL Industries (EPA:EXE) Will Be Hoping To Turn Its Returns On Capital Around

Oct 04
EXEL Industries (EPA:EXE) Will Be Hoping To Turn Its Returns On Capital Around

Is It Too Late To Consider Buying EXEL Industries SA (EPA:EXE)?

Mar 24
Is It Too Late To Consider Buying EXEL Industries SA (EPA:EXE)?

EXEL Industries (EPA:EXE) Has More To Do To Multiply In Value Going Forward

Dec 08
EXEL Industries (EPA:EXE) Has More To Do To Multiply In Value Going Forward

Is It Time To Consider Buying EXEL Industries SA (EPA:EXE)?

Nov 01
Is It Time To Consider Buying EXEL Industries SA (EPA:EXE)?

Does EXEL Industries (EPA:EXE) Have A Healthy Balance Sheet?

Jul 12
Does EXEL Industries (EPA:EXE) Have A Healthy Balance Sheet?

EXEL Industries (EPA:EXE) Has Some Difficulty Using Its Capital Effectively

May 31
EXEL Industries (EPA:EXE) Has Some Difficulty Using Its Capital Effectively

At €67.80, Is EXEL Industries SA (EPA:EXE) Worth Looking At Closely?

Apr 08
At €67.80, Is EXEL Industries SA (EPA:EXE) Worth Looking At Closely?

Calculating The Intrinsic Value Of Exel Industries Société Anonyme (EPA:EXE)

Mar 10
Calculating The Intrinsic Value Of Exel Industries Société Anonyme (EPA:EXE)

These Metrics Don't Make Exel Industries Société Anonyme (EPA:EXE) Look Too Strong

Feb 15
These Metrics Don't Make Exel Industries Société Anonyme (EPA:EXE) Look Too Strong

What Type Of Returns Would Exel Industries Société Anonyme's(EPA:EXE) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Jan 25
What Type Of Returns Would Exel Industries Société Anonyme's(EPA:EXE) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Gewinn- und Umsatzwachstumsprognosen

ENXTPA:EXE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
9/30/20261,1725044753
9/30/20251,1204542694
9/30/20241,1114335674
3/31/20241,10443-320N/A
12/31/20231,099432952N/A
9/30/20231,094426283N/A
6/30/20231,074372851N/A
3/31/20231,05331-720N/A
12/31/20221,01530-38-11N/A
9/30/202297729-69-42N/A
6/30/202293830-26-4N/A
3/31/2022898311733N/A
12/31/2021888373248N/A
9/30/2021877434763N/A
6/30/2021851424458N/A
3/31/2021825404153N/A
12/31/2020790154253N/A
9/30/2020754-114354N/A
6/30/2020748-225163N/A
3/31/2020742-335872N/A
12/31/2019759-154456N/A
9/30/201977742940N/A
6/30/2019811201627N/A
3/31/201984536315N/A
12/31/201884238-511N/A
9/30/201883939-127N/A
6/30/201885240-417N/A
3/31/201886441427N/A
12/31/201786943N/A49N/A
9/30/201787445N/A70N/A
3/31/201776233N/AN/AN/A
12/31/201675932N/AN/AN/A
9/30/201675632N/A58N/A
2/29/201674442N/A35N/A
11/30/201573537N/A37N/A
8/31/201572532N/A39N/A
5/31/201572929N/A22N/A
2/28/201573227N/A6N/A
11/30/201475430N/A13N/A
8/31/201477534N/A21N/A
5/31/201477433N/A26N/A
2/28/201477232N/A32N/A
11/30/201375630N/A17N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: EXEDas prognostizierte Gewinnwachstum (5.7% pro Jahr) liegt über der Sparquote (1.2%).

Ertrag vs. Markt: EXEDie Erträge des Unternehmens (8.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt French (10.9% pro Jahr).

Hohe Wachstumserträge: EXEDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: EXEDie Einnahmen des Unternehmens (2.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt French (5.8% pro Jahr).

Hohe Wachstumseinnahmen: EXEDie Einnahmen des Unternehmens (2.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: EXEDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.2%).


Wachstumsunternehmen entdecken